{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:05:19Z","timestamp":1789182319110,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CP23\/00009"],"award-info":[{"award-number":["CP23\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Biomedical Research Network Centre for Infectious Diseases","doi-asserted-by":"publisher","award":["CB21\/13\/00077"],"award-info":[{"award-number":["CB21\/13\/00077"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Biomedical Research Network Centre for Infectious Diseases","doi-asserted-by":"publisher","award":["CB21\/13\/00011"],"award-info":[{"award-number":["CB21\/13\/00011"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014365","name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013543","name":"European Society for Paediatric Infectious Diseases","doi-asserted-by":"publisher","award":["2023-II-PI-NOV-01"],"award-info":[{"award-number":["2023-II-PI-NOV-01"]}],"id":[{"id":"10.13039\/100013543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jiph.2026.103207","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:08:06Z","timestamp":1773335286000},"page":"103207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of long-acting therapies for the HIV treatment in the Spanish pediatric cohort (CoRISpe)"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8254-9085","authenticated-orcid":false,"given":"Beatriz","family":"Lazaro-Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tarancon-Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"\u00c1lvarez Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Garrote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Epalza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Reus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Del Carmen","family":"Vicent Castell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider O\u00f1ate","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-7405","authenticated-orcid":false,"given":"Miguel","family":"Torralba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5217-3726","authenticated-orcid":false,"given":"Javier","family":"Garc\u00eda-Abell\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-0032","authenticated-orcid":false,"given":"Jos\u00e9 Rafael","family":"Bret\u00f3n-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/COH.0000000000000904","article-title":"Use of long-acting injectable cabotegravir\/rilpivirine in people with HIV and adherence challenges","volume":"20","author":"Christopoulos","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"10.1016\/j.jiph.2026.103207_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/INF.0000000000004742","article-title":"Efficacy, safety and retention in care among adolescents and youth with HIV on long-acting injectable cabotegravir\/rilpivirine treatment: real-world observational cohort outcomes","volume":"44","author":"Williams","year":"2025","journal-title":"Pedia Infect Dis J"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jpids\/piac134","article-title":"Long-acting antiretroviral drug therapy in adolescents: current status and future prospects","volume":"12","author":"Freij","year":"2023","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"12","key":"10.1016\/j.jiph.2026.103207_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jiph.2026.103207_bib5","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/INF.0000000000000584","article-title":"Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents","volume":"34","author":"Bunupuradah","year":"2015","journal-title":"Pedia Infect Dis J"},{"issue":"8","key":"10.1016\/j.jiph.2026.103207_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciw487","article-title":"Virological and social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care","volume":"63","author":"Weijsenfeld","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103207_bib7","article-title":"The Epidemiology of Adolescents Living with Perinatally Acquired HIV: A Cross-region Global Cohort analysis","author":"The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration","year":"2018"},{"issue":"3","key":"10.1016\/j.jiph.2026.103207_bib8","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2352-3018(24)00344-8","article-title":"Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017\/MOCHA): a phase 1\/2, multicentre, open-label, non-comparative, dose-finding study","volume":"12","author":"Moore","year":"2025","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-13-2","article-title":"A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)","volume":"13","author":"De Jose","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2026.103207_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/QAI.0000000000002539","article-title":"Clinical, immunological, and virological outcomes among youths with perinatal HIV after transition to adult units in Spain from 1997 to 2016","volume":"86","author":"Aguilera-Alonso","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1186\/s12879-024-09904-x","article-title":"Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting","volume":"24","author":"Konishi","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/QAI.0000000000003500","article-title":"Acceptability of Long-Acting Cabotegravir + Rilpivirine in a Large, Urban, Ambulatory HIV Clinic","volume":"97","author":"Luc","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.jiph.2026.103207_bib13","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s10461-020-02918-x","article-title":"Efficacy and freedom: patient experiences with the transition from daily oral to long-acting injectable antiretroviral therapy to treat HIV in the context of Phase 3 trials","volume":"24","author":"Mantsios","year":"2020","journal-title":"AIDS Behav"},{"issue":"8","key":"10.1016\/j.jiph.2026.103207_bib14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14787210.2022.2081153","article-title":"Cabotegravir\/rilpivirine: the last FDA-approved drug to treat HIV","volume":"20","author":"Taki","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/j.jiph.2026.103207_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jpids\/piae033","article-title":"Off-label use of long-acting injectable antiretroviral therapy: a single center retrospective review of youth living with HIV with detectable HIV RNA starting injectable therapy","volume":"13","author":"Rousseau","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jiph.2026.103207_bib16","unstructured":"A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN). November 2024. \u3008https:\/\/clinicaltrials.gov\/study\/NCT06694805\u3009. Accessed December 2, 2024."},{"key":"10.1016\/j.jiph.2026.103207_bib17","article-title":"CD4\/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis","volume":"15","author":"Ron","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12879-025-10469-6","article-title":"The CD4\/CD8 ratio is associated with T lymphocyte functions in long-term virally suppressed patients with HIV","volume":"25","author":"Xiao","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.jiph.2026.103207_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/QAD.0000000000001533","article-title":"CD4+\/CD8 + ratio restoration in long-term treated HIV-1-infected individuals","volume":"31","author":"Caby","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jiph.2026.103207_bib20","series-title":"PLoS One","article-title":"Increased Risk of Serious Non-AIDS-related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with A Low CD4\/CD8 Ratio","author":"Serrano-Villar","year":"2014"},{"key":"10.1016\/j.jiph.2026.103207_bib21","article-title":"HIV-Infected Individuals with Low CD4\/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality","volume":"10","author":"Serrano-Villar","year":"2014"},{"issue":"10","key":"10.1016\/j.jiph.2026.103207_bib22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciw076","article-title":"Determinants of a low CD4\/CD8 ratio in HIV-1\u2013infected individuals despite long-term viral suppression","volume":"62","author":"Caby","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.jiph.2026.103207_bib23","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/QAD.0000000000003984","article-title":"CD4+\/CD8+ improvement after switch from a second-generation integrase inhibitor regimen to long-acting cabotegravir and rilpivirine","volume":"38","author":"Muccini","year":"2024","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.jiph.2026.103207_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25804","article-title":"Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain","volume":"24","author":"Carrasco","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"10.1016\/j.jiph.2026.103207_bib25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/QAD.0b013e32835faa72","article-title":"The CD4\/CD8 ratio as a marker T-cell activation, senescence and activation\/exhaustion in treated HIV-infected children and young adults","volume":"27","author":"Sainz","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jiph.2026.103207_bib26","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1210\/clinem\/dgad411","article-title":"Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications","volume":"109","author":"Chandiwana","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jiph.2026.103207_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae479","article-title":"Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America","author":"Horberg","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/hiv.13017","article-title":"Association of body mass index with immune recovery, virological failure and cardiovascular disease risk among people living with HIV","volume":"22","author":"Han","year":"2021","journal-title":"HIV Med"},{"issue":"9","key":"10.1016\/j.jiph.2026.103207_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/hiv.12259","article-title":"Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010","volume":"16","author":"Koethe","year":"2015","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12879-019-3991-6","article-title":"Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China","volume":"19","author":"Li","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/s41598-024-84498-7","article-title":"Impact of obesity on iron metabolism and the effect of intravenous iron supplementation in obese patients with absolute iron deficiency","volume":"15","author":"Tarancon-Diez","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2026.103207_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670566","article-title":"Contribution of adipose tissue to the chronic immune activation and inflammation associated with HIV infection and its treatment","volume":"12","author":"Bourgeois","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAD.0000000000000893","article-title":"The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy","volume":"30","author":"Koethe","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/infdis\/jiw096","article-title":"Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults","volume":"214","author":"Mave","year":"2016","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000002466","article-title":"Long-acting injectable cabotegravir + rilpivirine for HIV maintenance therapy: week 48 pooled analysis of Phase 3 ATLAS and FLAIR trials","volume":"85","author":"Rizzardini","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.jiph.2026.103207_bib36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dkae480","article-title":"Safety and efficacy of long-acting cabotegravir\/rilpivirine versus standard oral antiretroviral therapy: a systematic review and meta-analysis","volume":"80","author":"Manalu","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jiph.2026.103207_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/hiv.70096","article-title":"Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics","volume":"26","author":"Adachi","year":"2025","journal-title":"HIV Med"},{"issue":"11","key":"10.1016\/j.jiph.2026.103207_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/v17111417","article-title":"Efficacy and safety of cabotegravir\u2013rilpivirine in PLWH: a real-world study","volume":"17","author":"Conti","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2026.103207_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1734023","article-title":"Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants","volume":"17","author":"Moreno-Lopez","year":"2026","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/INF.0000000000003009","article-title":"Mortality in perinatally HIV-infected adolescents after transition to adult care in Spain","volume":"40","author":"Berzosa S\u00e1nchez","year":"2021","journal-title":"Pedia Infect Dis J"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00251-020-01202-5","article-title":"Differences in pyroptosis of recent thymic emigrants CD4+ T Lymphocytes in ART-treated HIV-positive patients are influenced by sex","volume":"73","author":"Andrade-Santos","year":"2021","journal-title":"Immunogenetics"},{"issue":"4","key":"10.1016\/j.jiph.2026.103207_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF03324966","article-title":"Differences according to gender and health status in CD4:CD8 ratio in a sample of community-dwelling oldest old. The OCTABAIX immune study","volume":"23","author":"Formiga","year":"2011","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.jiph.2026.103207_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73870-2","article-title":"Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV","volume":"14","author":"Tarancon-Diez","year":"2024","journal-title":"Sci Rep"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:28:23Z","timestamp":1776194903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126000791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1876034126000791"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103207","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of long-acting therapies for the HIV treatment in the Spanish pediatric cohort (CoRISpe)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103207"}}